BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 10:03:00 AM | Browse: 990 | Download: 946
Publication Name World Journal of Diabetes
Manuscript ID 8043
Country/Territory United States
Received
2013-12-12 16:56
Peer-Review Started
2013-12-13 08:17
To Make the First Decision
2014-01-16 08:12
Return for Revision
2014-01-17 13:16
Revised
2014-01-30 04:26
Second Decision
2014-05-08 17:40
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-08 17:53
Articles in Press
2014-05-23 09:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-06-13 21:03
Publish the Manuscript Online
2014-06-16 15:44
ISSN 1948-9358 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Engineering, Biomedical
Manuscript Type Topic Highlights
Article Title Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia
Manuscript Source Invited Manuscript
All Author List Hyun Joon Paek, Courtney Kim and Stuart K Williams
Funding Agency and Grant Number
Corresponding Author Hyun Joon Paek, PhD, Director, Biologics, Tissue Genesis Institute, LLC, 810 Richards Street, Suite 1000, Honolulu, HI 96813, United States. jpaek@tissuegenesis.com
Key Words Diabetes mellitus; Diabetes; Insulin; Stem cells; Adipose; Pancreas; Beta-cells; Differentiation
Core Tip Adipose-derived stem cells (ADSCs) can provide a promising cell therapy for treatment of diabetes and associated complications. ADSCs’ multipotency allows differentiation into insulin-producing ?-cells. Anti-inflammatory and immunomodulatory capabilities of ADSCs can facilitate enhanced engraftment of transplanted donor islets. Although many challenges lie ahead for ADSC-based cell therapies are used clinically to treat diabetic hyperglycemia, ADSCs represent a novel treatment option to many diabetic patients worldwide.
Publish Date 2014-06-16 15:44
Citation Paek HJ, Kim C, Williams SK. Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia. World J Diabetes 2014; 5(3): 235-243
URL http://www.wjgnet.com/1948-9358/full/v5/i3/235.htm
DOI http://dx.doi.org/10.4239/wjd.v5.i3.235
Full Article (PDF) WJD-5-235.pdf
Full Article (Word) WJD-5-235.doc
Manuscript File 8043-Review.docx
Answering Reviewers 8043-Answering reviewers.pdf
Copyright License Agreement 8043-Copyright assignment.pdf
Peer-review Report 8043-Peer review(s).pdf
Scientific Editor Work List 8043-Scientific editor work list.pdf